Biogen Inc. buy Wells Fargo & Company
Start price
09.11.23
/
50%
€210.20
Target price
09.11.24
€340.62
Performance (%)
0.33%
Price
03.06.24
€210.90
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Biogen Inc. is nearly unchanged. This prediction currently runs until 09.11.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 4.925% | 4.925% |
iShares Core DAX® | -1.226% | 2.804% |
iShares Nasdaq 100 | -1.845% | 2.732% |
iShares Nikkei 225® | -1.132% | -2.218% |
iShares S&P 500 | -0.980% | 1.883% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Wells Fargo & Company from $343.00 to $365.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat